PMC:6640909 / 127749-128873 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6640909","sourcedb":"PMC","sourceid":"6640909","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6640909","text":"ACKNOWLEDGEMENTS\nThe authors would like to thank Rianne Kalkman for her expertise and help in writing and reviewing this expert consensus.\nConflict of interest: Evgenij V. Potapov: Institutional research and travel grants, consulting and proctoring fees from Abbott and Medtronic. Maria G. Crespo-Leiro: Research support from Novartis, Vifor Pharma, and FEDER Funds; personal fees (travel grants, lecture fees and/or advisory boards) from Novartis, Abbott Vascular, Astellas, MSD, Amgen, Sanofi and Servier. Lars H. Lund: Speaker's honoraria from Abbott. Ivan Netuka: Consultant, grant, advisory board Abbott; USA; advisory board and a principal investigator of the CE Mark Stud Carmat SA, France; advisory board EvaHeart Inc., USA; advisory board, stockholder LeviticusCardio Ltd, Israel. Steven Tsui: Consultant for CorWave Ltd and 3R Ltd; research support from Maquet Getinge group. Daniel Zimpfer: Proctor, advisor, research and travel grants from Abbott and Medtronic. Finn Gustafsson: Advisor: Carmat, Corvia, Pfizer. Speaker: Abbott, Orion Pharma, Novartis. The other authors have no conflict of interest to disclose.","divisions":[{"label":"title","span":{"begin":0,"end":16}},{"label":"p","span":{"begin":17,"end":138}}],"tracks":[]}